Vivo 2Q net operating revenue R$15.76B, estimate R$15.59B

Vivo reported second-quarter net operating revenue of R$15.76 billion, slightly exceeding the estimated R$15.59 billion. This performance reflects the company’s continued ability to meet or surpass market expectations in key financial metrics. The results align with recent trends of consistent earnings and revenue growth, as demonstrated by the company’s historical performance, including its Q4 2022 earnings report, where it beat estimates by 33.33%.

Meridian Bioscience, another entity under the VIVO ticker, has similarly shown strong quarterly performance, with earnings and revenue figures surpassing consensus estimates in recent reporting periods. Investors are closely monitoring how these results influence future earnings expectations and stock price movements. The next earnings call for VIVO is scheduled for July 21, 2026, offering stakeholders an opportunity to gain further insight into the company’s financial outlook and strategic direction.